Fabino Life Sciences Ltd - Stock Valuation and Financial Performance

BSE: 543444 | NSE: | Pharmaceuticals & Drugs | Small Cap

Fabino Life Sciences Share Price

39.57 0.00 0.00%
as on 26-Feb'24 16:59

DeciZen - make an informed investing decision on Fabino Life Sciences

M-Cap below 100cr DeciZen not available

Fabino Life Sciences stock performance -

mw4me loader
P/E Ratio (SA):
769.42
Market Cap:
8.3 Cr.
52-wk low:
25.5
52-wk high:
43.8

Is Fabino Life Sciences Ltd an attractive stock to invest in?

1. Is Fabino Life Sciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Fabino Life Sciences Ltd is a below average quality company.

2. Is Fabino Life Sciences Ltd undervalued or overvalued?

The key valuation ratios of Fabino Life Sciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Fabino Life Sciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Fabino Life Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Fabino Life Sciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Fabino Life Sciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 6.5%8.6%2.1%1.8%0.5%-
Value Creation
Index
-0.5-0.4-0.9-0.9-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2.87.53.14.23.43
Sales YoY Gr.-172.5%-59.3%37.3%-20%-
Adj EPS 01.20.30.20.10.1
YoY Gr.-NA-78.3%-12%-77.3%-
BVPS (₹) 044.810.919.519.619.6
Adj Net
Profit
00.100.100
Cash Flow from Ops. 0.22.4-0.5-1.9-0.7-
Debt/CF from Ops. 13.60.4-0.7-0-0.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-23.6%-20%
Adj EPS NANA-64.8%-77.3%
BVPSNANA-24.1%0.3%
Share Price - - - 26%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
010.83.11.70.30.3
Op. Profit
Mgn %
11.64.22.12.11NAN
Net Profit
Mgn %
00.911.10.30.3
Debt to
Equity
4.21.60.200.1-
Working Cap
Days
02833192554600
Cash Conv.
Cycle
0-2371501863250

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 0.30%

Sales growth has been subdued in last 3 years -23.55%

Net Profit has been subdued in last 3 years -64.84%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Fabino Life Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 3.4 -
BVPS (₹.) 19.6 -
Reserves (₹ Cr.) 2 -
P/BV 2.02 -
PE 769.42 -
From the Market
52 Week Low / High (₹) 25.50 / 43.84
All Time Low / High (₹) 22.50 / 48.95
Market Cap (₹ Cr.) 8.3
Equity (₹ Cr.) 2.1
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of Fabino Life Sciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Fabino Life Sciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Sales2.767.523.064.203.36
Operating Expenses 2.447.202.994.113.33
Manufacturing Costs0.0300.040.060.04
Material Costs1.826.892.733.572.95
Employee Cost 0.300.210.090.190.19
Other Costs 0.290.100.130.290.14
Operating Profit 0.320.320.060.090.03
Operating Profit Margin (%) 11.6%4.2%2.1%2.1%1.0%
Other Income 0000.010.02
Interest 0.290.200.010.010.01
Depreciation 0.030.020.020.030.03
Exceptional Items 00000
Profit Before Tax 00.100.040.070.01
Tax 00.030.010.020
Profit After Tax 00.070.030.050.01
PAT Margin (%) 0.0%0.9%1.0%1.1%0.3%
Adjusted EPS (₹)0.01.20.30.20.1
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 0.600.671.304.104.11
Share Capital 0.150.151.202.102.10
Reserves 0.450.520.1022.01
Minority Interest00000
Debt2.521.080.310.050.41
Long Term Debt0.141.080.310.050.41
Short Term Debt2.380000
Trade Payables5.111.460.480.340.37
Others Liabilities 0.310.360.150.130.11
Total Liabilities 8.543.582.244.625

Fixed Assets

Gross Block0.220.220.160.170.18
Accumulated Depreciation0.120.14000.03
Net Fixed Assets0.100.080.160.170.15
CWIP 00000
Investments 00000
Inventories4.930.290.471.711.19
Trade Receivables2.562.331.331.442.53
Cash Equivalents 0.100.170.070.590.24
Others Assets0.860.700.220.710.89
Total Assets 8.543.582.244.625

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0.182.44-0.45-1.90-0.68
PBT 00.100.040.070.01
Adjustment 0.320.220.020.030.04
Changes in Working Capital -0.132.15-0.48-2-0.71
Tax Paid 0-0.03-0.030-0.01
Cash Flow From Investing Activity -0.010-0.10-0.05-0.01
Capex -0.010-0.09-0.05-0.01
Net Investments 00000
Others 00-0.0100
Cash Flow From Financing Activity -0.18-2.370.452.470.34
Net Proceeds from Shares 000.602.750
Net Proceeds from Borrowing 00-0.09-0.260.36
Interest Paid -0.29-0.20000
Dividend Paid 00000
Others 0.12-2.17-0.07-0.02-0.02
Net Cash Flow 00.07-0.100.52-0.35
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)0.0210.83.051.740.26
ROCE (%)9.4412.362.922.480.58
Asset Turnover Ratio0.321.241.051.230.7
PAT to CFO Conversion(x)INF34.86-15-38-68
Working Capital Days
Receivable Days338119218120215
Inventory Days6511274695157
Payable Days1,0241741304244

Fabino Life Sciences Ltd Stock News

Fabino Life Sciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Fabino Life Sciences on 26-Feb-2024 16:59 is ₹39.57.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 26-Feb-2024 16:59 the market cap of Fabino Life Sciences stood at ₹8.31.
The latest P/E ratio of Fabino Life Sciences as of 26-Feb-2024 16:59 is 769.4.
The latest P/B ratio of Fabino Life Sciences as of 26-Feb-2024 16:59 is 2.02.
The 52-week high of Fabino Life Sciences is ₹43.84 and the 52-week low is ₹25.50.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fabino Life Sciences is ₹3.36 ( Cr.) .

About Fabino Life Sciences Ltd

Fabino Life Sciences is a growing pharmaceutical and other wellness focused consumer Products Company operating from Delhi and Haryana. The company’s product range is bifurcated into brands-Fabino and Keepshine. Fabino is the Brand under which it markets all of its pharmaceutical products including Tablets, Ointments Syrups etc for various medical treatments in its allopathic and certain herbal range. Keepshine is the Brand under which it markets its Shampoo and Hair Maintenance products. It exports wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which are marketed by the company. The company emphasizes developing high-quality and affordable products for all sections of society by harnessing the skills of its competent manpower and other resources. It aims at providing the best quality products at affordable rates for good health and well-being for all.

Business area of the company

The company is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness focused consumer products. The company’s core business is marketing of pharmaceutical formulation & products in domestic market through own distribution network and sales force under own brand name, getting its ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc.

Major events in the history

  • October 2011: Incorporation of Company as ‘Fabino Life Sciences Private Limited’.
  • March 2015: Conversion of Company from ‘Private Limited’ to ‘Public Limited’.
  • May 2020: Obtained License to Manufacture Ayurvedic/Unani/Sidha Medicines.
  • January 2021: Obtained ISO 9001:2015 certifying the quality management system, confirming the scope of manufacturing and Marketing of medicines, Food supplements, Herbal medicines, Veterinary medicines, Packaging material, etc.
  • February 2021: Obtained Permission for Export of coffee from Coffee Board.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.